News and Conferences

One of Transpharmation's scientists, Caoimhe Tyndall will be presenting a poster titled 'Assessing the immunogenicity of alpha-synuclein oligomers,filaments and fibrils in a clinically relevant model of synucleinopathy in-vitro' (poster P529) at our virtual booth. InterVivo Solutions, who Transpharmation merged with in January this year, will be hosting an in-person booth at this conference in Barcelona. Whichever you decide to attend, we look forward to seeing you!

For further information on this event click here: https://adpd.kenes.com/

Only 14 establishments in the UK hold this globally recognised accreditation and we’re very proud of Agenda Life Sciences for impressing the team that carried out the assessment.

Read Gareth Macdonald's feature ...

North American CRO, InterVivo Solutions, and UK/ Europe-based, Transpharmation, have come together as sister companies with a joint management team, following years of collaboration and joint ventures between the two.

Transpharmation’s labs in Poland have new visitors. Danio rerio, more commonly known as zebrafish, have taken up residence to help develop a package of research methods enabling high-throughput screening of new substances with potential therapeutic effects in disorders of the central nervous system, including psychiatry disorders, neurodegenerative diseases, congenital defects, hereditary diseases, neuroimmunology and epilepsy. The model organism used in the first stage of screening will be a danio rerio embryo or larvae. Read more ...

With preclinical/clinical transition being the largest failure risk in CNS therapeutics development, join us at HubXchange’s CNS Therapeutics Europe 2021 roundtable meeting, where senior drug developers from pharma and biotech share experiences and discuss the future research landscape. Jack Prenderville, Head of Transpharmation Ireland, will be presenting a poster on our latest neuroinflammation studies. Join him between 3.10 – 3.40pm CET, December 2nd, under preclinical discussion.

For more information on this event: https://www.hub-xchange.com/xchanges/

The Society for Neuroscience will hold Neuroscience 2021 as a fully virtual experience, eliminating all in-person options that had been planned for McCormick Place in Chicago, Illinois. Neuroscience 2021 will take place online November 8-11, 2021, with Preview Days taking place November 3-7, which allow attendees to preview posters as well as full symposia and minisymposia talks prior to the official meeting dates. Transpharmation has nine posters prepared across a range of topical and popular preclinical areas which will be revealed to you from our booth 1818. We look forward to connecting with you.

All poster presentations from this annual conference are now available on our YouTube channel

If you would like to discuss any of these in more detail with us please contact us . Thank you.

For more information on the event please visit: https://www.sfn.org/meetings/neuroscience-2021

Neurex is one of the most important European networks in the field of Neuroscience and this is their first online Neurex lab-companies Neuroforum, an event aimed at gathering all the protagonists of the Neuroscience R&D dynamics. Transpharmation will be hosting a booth during the event, please drop in to find out all about the preclinical therapeutic areas in which we can help with your studies.

The annual ECNP Congress is Europe’s premier scientific meeting for disease-oriented brain research, annually attracting more than 5,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world. Transpharmation will be presenting a poster on “Rapid-acting antidepressants in motivation: the effects of low-dose ketamine and the psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) in the rat progressive ratio task

To view our presentation click here https://youtu.be/9j-BoWpEEvA 
For more information on this event: https://www.ecnp.eu/Congress2021/ECNPcongress

Cannabinoids and Psychedelics; Neuroscience Ireland Meeting 2021 - 9th-10th September 2021

The Neuroscience Ireland 2021 meeting will be held virtually on 9th and 10th September 2021.The programme features 2 poster sessions, 4 themed symposia, 3 Plenary lectures and the Tom Connor Distinguished Investigator Award Prize Lecture. Click here to view the full programme https://neuroscienceireland.com/category/neuroscience-ireland-meeting-2021/ Dr Jack Prenderville, Head of Transpharmation Ireland will be presenting on 10th September, at 11.00 BST, focusing on Cannabinoids and Psychedelics with a look at innovative approaches to therapeutics to improve human health, with particular attention on the cannabinoid system and psychedelics in mental health, multiple sclerosis and ocular inflammatory disease.

Please click here to view our presentation